Cyanoacrylate ablation for chronic venous disease: a review and future applications
Kathleen Ozsvath, MD, FACS Chief of Surgery, Samaritan Hospital, Troy, New York; Vascular Associates, St Peters Health Partners, Albany, New York; Professor of Surgery, Albany Medical Center, Albany, New York, USA ABSTRACT Many endovenous procedural modalities exist today, including endovenous thermal ablation (laser ablation, [EVLT] and radiofrequency ablation [RFA]), nonthermal nontumescent ablation, and ultrasound-guided sclerotherapy (UGS) and chemical ablation. Recently, cyanoacrylate has been used for the treatment of axial insufficiency. The most studied preparation of N-butyl cyanoacrylate is VenaSeal (Medtronic), which has been compared with the other ablative techniques. These studies have shown excellent results with patient satisfaction, outcomes, and…